|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.602
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.452
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.388
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.378
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.347
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.323
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.315
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.303
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.295
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.290
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.289
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.266
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.260
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.253
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.251
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.251
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.249
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.247
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.246
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.234
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.227
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.225
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.218
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.214
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.214
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.214
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.211
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.207
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.207
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.202
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.199
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.197
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.181
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.181
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.181
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.180
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.179
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.171
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.166
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.160
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.157
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.153
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.153
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.150
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.150
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.147
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.145
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.144
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.142
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.138
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.137
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.134
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.133
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.133
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.133
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.128
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.119
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.115
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.112
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.112
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.109
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.109
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.106
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.103
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.097
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.095
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.093
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.091
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.090
|
Mouse |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.089
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.087
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.083
|
Mouse |
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.082
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.080
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.078
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.074
|
Mouse |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.073
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.071
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.071
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.070
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.070
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.068
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.068
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.067
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.066
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.066
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.065
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.064
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.063
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.062
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.062
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.060
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.060
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.060
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.059
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.059
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.058
|
Mouse |
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.058
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.058
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.057
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.056
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.053
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.052
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.051
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.050
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.049
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.049
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.048
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.048
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.048
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.048
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.047
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.046
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.044
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.044
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.044
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.044
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.043
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.043
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.043
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.042
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.042
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.042
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.042
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.041
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.041
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.041
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.041
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.040
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.039
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.039
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.039
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.039
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.038
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.038
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.038
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.038
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.037
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.037
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.037
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.036
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.036
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.036
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.036
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.036
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.035
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.035
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.035
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.034
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.034
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.034
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.033
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.033
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.033
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.033
|
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.033
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.033
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.033
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.033
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.031
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.031
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.031
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.030
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.030
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.030
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.030
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.030
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.030
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.029
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.029
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.029
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.029
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.029
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.029
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.029
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.029
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.029
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.029
|
Mouse |
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.028
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.028
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.028
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.028
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.028
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.028
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.027
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.027
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.027
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.027
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.027
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.027
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.027
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.027
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.027
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.027
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.026
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.026
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.026
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.026
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.026
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.026
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.026
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.025
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.025
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.025
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.025
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.025
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.025
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.025
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.025
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.025
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.024
|
Mouse |
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.024
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.024
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.024
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.024
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.024
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.024
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.024
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.024
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.024
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.023
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.023
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.023
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.023
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.023
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.023
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.023
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.023
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.023
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.023
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.023
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.022
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.022
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.022
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.022
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.022
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.022
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.022
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.022
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.022
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.022
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.022
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.021
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.021
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.021
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.021
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.021
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.021
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.021
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.021
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.021
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.021
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.021
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.021
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.020
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.020
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.020
|
|
|
|
positive regulation of tor signaling
|
GO:0032008 |
3 |
0.020
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.020
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.020
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.020
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.020
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.020
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.020
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.020
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.020
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.019
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.019
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.019
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.019
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.019
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.019
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.019
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.019
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.019
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.019
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.019
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.019
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.019
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.019
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.019
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.019
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.019
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.019
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.019
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.018
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.018
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.018
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.018
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.018
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.018
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.018
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.018
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.018
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.018
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.018
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.018
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.018
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.018
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.018
|
|
|
|
growth involved in heart morphogenesis
|
GO:0003241 |
4 |
0.018
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.017
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.017
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.017
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.017
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.017
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.017
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.017
|
|
|
|
regulation of adrenergic receptor signaling pathway
|
GO:0071877 |
4 |
0.017
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.017
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.017
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.017
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.017
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.017
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.017
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.017
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.017
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.017
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.017
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.017
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.017
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.017
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.017
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.017
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.017
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.017
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.016
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.016
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.016
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.016
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.016
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.016
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.016
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.016
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.016
|
|
|
|
negative regulation of protein kinase activity by regulation of protein phosphorylation
|
GO:0044387 |
2 |
0.016
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.016
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.016
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.016
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.016
|
|
|
|
positive regulation of creb transcription factor activity
|
GO:0032793 |
4 |
0.016
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.016
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.016
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.016
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.016
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.016
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.016
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.016
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.015
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.015
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.015
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.015
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.015
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.015
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.015
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.015
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.015
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.015
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.015
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.015
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.015
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.015
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.015
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.015
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.015
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.015
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.015
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.015
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.015
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.014
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.014
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.014
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.014
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
Mouse |
|
|
organ growth
|
GO:0035265 |
117 |
0.014
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.014
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.014
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.014
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.014
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.014
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.014
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.014
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.014
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.014
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.014
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.014
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.014
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.014
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.014
|
|
|
|
regulation of cellular response to insulin stimulus
|
GO:1900076 |
30 |
0.014
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.014
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.014
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.014
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.014
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.014
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.014
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.014
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.014
|
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.014
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.014
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.013
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.013
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.013
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.013
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.013
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.013
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.013
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.013
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.013
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.013
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.013
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.013
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.013
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.013
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.013
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.013
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.013
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.013
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.013
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.013
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.013
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.013
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.013
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.013
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.013
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.013
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.013
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.013
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.013
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.013
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.013
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.013
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.013
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.013
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.013
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.013
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.013
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.013
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.013
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.013
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.012
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.012
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.012
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.012
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.012
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.012
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.012
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.012
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.012
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.012
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.012
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.012
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.012
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.012
|
|
|
|
learning
|
GO:0007612 |
98 |
0.012
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.012
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.012
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.012
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.012
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.012
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.012
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.012
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.012
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.012
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.012
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.012
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.012
|
|
|
|
semaphorin plexin signaling pathway involved in bone trabecula morphogenesis
|
GO:1900220 |
2 |
0.012
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.012
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.012
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.012
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.012
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.012
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.012
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.012
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.012
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.011
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.011
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.011
|
|
|
|
cgmp catabolic process
|
GO:0046069 |
2 |
0.011
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.011
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.011
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.011
|
|
|
|
regulation of vacuole organization
|
GO:0044088 |
4 |
0.011
|
|
|
|
rap protein signal transduction
|
GO:0032486 |
3 |
0.011
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.011
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.011
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.011
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.011
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.011
|
|
|
|
translation
|
GO:0006412 |
93 |
0.011
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.011
|
|
